长江中游城市群生物医药产业发展具有良好的基础,在人才、研发能力、临床、产业集群化等方面具有较大的优势。近年来,长江中游城市群生物医药产业发展速度和效益稳步增长,逐步从“制造”向“智造”升级,产业集聚态势明显,产业布局进一步优化。当前,应进一步加快专业化生物医药科技服务平台建设,加大财税金融支持力度,加强各类专业人才引培,营造开放包容的创新环境,大力推进科技服务与生物医药产业集群的协同发展。
<<The urban agglomeration in the middle reaches of the Yangtze River has a good foundation of biomedical industry,and also has great advantages in talents,research and development capabilities,clinical,and industrial clustering. In recent years,the developing speed and efficiency of the biomedicine industry in Urban agglomeration in the middle reaches of the Yangtze River have grown steadily,gradually upgrading from “manufacturing” to “intelligent manufacturing”,the trend of industrial agglomeration is obvious,and the industrial layout has been further optimized. At present,it is necessary to further accelerate the construction of specialized biomedical science and technology service platforms,increase financial,taxation and financial support,strengthen the introduction and training of various professional talents,create an open and inclusive innovation environment,and vigorously promote the coordinated development of science and technology services and biomedical industry clusters.
<<Keywords: | Industrial ClusterCoordinated DevelopmentTechnology ServicesUrban Agglomeration in the Middle Reaches of the Yangtze RiverBiomedicine |